U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry MIXED
Molecular Formula C6H10O3
Molecular Weight 130.1418
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BIS(2,3-EPOXYPROPYL) ETHER

SMILES

C(OCC1CO1)C2CO2

InChI

InChIKey=GYZLOYUZLJXAJU-UHFFFAOYSA-N
InChI=1S/C6H10O3/c1(5-3-8-5)7-2-6-4-9-6/h5-6H,1-4H2

HIDE SMILES / InChI
Molecular Formula C6H10O3
Molecular Weight 130.1418
Charge 0
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Correlation of apoptotic potential of simple oxiranes with cytotoxicity.
2006-08
Stability of silorane dental monomers in aqueous systems.
2006-07
First steps towards tissue engineering of small-diameter blood vessels: preparation of flat scaffolds of collagen and elastin by means of freeze drying.
2006-05
Effects of conditions for preparing nanoparticles composed of aminoethylcarbamoyl-beta-cyclodextrin and ethylene glycol diglycidyl ether on trap efficiency of a guest molecule.
2006-03-27
Determination of bisphenol diglycidyl ethers in topical dosage forms.
2006-02-13
Trap and release of oligonucleotide using pH-responsive amphoteric particle prepared by interfacial polymerization in W/O miniemulsion system.
2006-02-05
Neuroprotective effects of stearic acid against toxicity of oxygen/glucose deprivation or glutamate on rat cortical or hippocampal slices.
2006-02
Alkylpurine-DNA-N-glycosylase excision of 7-(hydroxymethyl)-1,N6-ethenoadenine, a glycidaldehyde-derived DNA adduct.
2006-01-05
Effects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells.
2005-12-01
Effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of retinoic acid-inducible gene-I in endothelial cells stimulated with lipopolysaccharide.
2005-12
Dietary exposure to chemical migrants from food contact materials: a probabilistic approach.
2005-10
Inhibitors of fatty acid amide hydrolase reduce carrageenan-induced hind paw inflammation in pentobarbital-treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors.
2005-10
PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
2005-10
Vertebroplasty by use of a strontium-containing bioactive bone cement.
2005-09-01
Improving glutamate microsensors by optimizing the composition of the redox hydrogel.
2005-09-01
[Characteristics of porcine thoracic arteries fixed with polyepoxy compound].
2005-09
Angiotensin II induces peroxisome proliferator-activated receptor gamma in PC12W cells via angiotensin type 2 receptor activation.
2005-09
[Simulation of migration from a multi-layer laminated film intended for retort foods].
2005-08
Contact vitiligo following a strong patch test reaction to triglycidyl-p-aminophenol in an aircraft industry worker: case report and review of the literature.
2005-08
Properties of acrylic bone cements formulated with Bis-GMA.
2005-08
An interference-free implantable glucose microbiosensor based on use of a polymeric analyte regulating membrane.
2005-05-01
Occupational allergic contact dermatitis to bisphenol F epoxy resin.
2005-05
DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach.
2005-05
Comment on "Thermal glass transition beyond the Vogel-Fulcher-Tammann behavior for glass forming diglycidylether of bisphenol A".
2005-04-01
Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population.
2005-04
Salivary bisphenol-A levels detected by ELISA after restoration with composite resin.
2005-04
15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
2005-04
EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism.
2005-03
Adsorption behaviour of Fe(II) and Fe(III) ions in aqueous solution on chitosan and cross-linked chitosan beads.
2005-03
Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury.
2005-02
Oral sustained delivery of diclofenac sodium using calcium chondroitin sulfate matrix.
2005
Determination of bisphenol F diglycidyl ether and related compounds by high-performance liquid chromatography/mass spectrometry.
2005
An attempt to improve diagnostics of contact allergy due to epoxy resin systems. First results of the multicentre study EPOX 2002.
2004-12-21
Modeling of complex viscosity changes in the curing of epoxy resins from near-infrared spectroscopy and multivariate regression analysis.
2004-12
Inhibition of cell proliferation by potential peroxisome proliferator-activated receptor (PPAR) gamma agonists and antagonists.
2004-11-03
Review of the toxicology, human exposure and safety assessment for bisphenol A diglycidylether (BADGE).
2004-09
Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.
2004-07-15
New methodology for the determination of phthalate esters, bisphenol A, bisphenol A diglycidyl ether, and nonylphenol in commercial whole milk samples.
2004-06-16
15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process.
2004-06-15
Study on anti-androgenic effects of bisphenol a diglycidyl ether (BADGE), bisphenol F diglycidyl ether (BFDGE) and their derivatives using cells stably transfected with human androgen receptor, AR-EcoScreen.
2004-06
Steroid activities comparison of natural and food wrap compounds in human breast cancer cell lines.
2004-06
Prediction of the formulation dependence of the glass transition temperatures of amine-epoxy copolymers using a QSPR based on the AM1 method.
2004-05-25
Biodegradable films of partly branched poly(l-lactide)-co-poly(epsilon-caprolactone) copolymer: modulation of phase morphology, plasticization properties and thermal depolymerization.
2004-05-11
Surface treatment of injectable strontium-containing bioactive bone cement for vertebroplasty.
2004-04-15
Determination of bisphenol A diglycidyl ether and its hydrolysis and chlorohydroxy derivatives by liquid chromatography-mass spectrometry.
2004-04-02
Migration from can coatings: part 3. Synthesis, identification and quantification of migrating epoxy-based substances below 1000 Da.
2004-04
Preferential solvation of poly(methyl methacrylate) and a bisphenol A diglycidyl ether by size-exclusion chromatography.
2004-03-26
15-Deoxy-delta(12,14)-prostaglandin J2 inhibits the IL-1beta-induced expression of granulocyte-macrophage colony-stimulating factor in BEAS-2B bronchial epithelial cells.
2004-02
Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells.
2004
Contact allergy to the isomers of diglycidyl ether of bisphenol F.
2004
Patents

Patents

JP1045423A
1
JP1071732A
3
JP2000063656A
1
JP2000104012A
3
JP2000119488A
1
JP2000178344A
1
JP2000198962A
1
JP2000281968A
1
JP2000302930A
1
JP2000303039A
1
JP2000319619A
3
JP2000500522A
1
JP2001011197A
3
JP2001031850A
1
JP2001114719A
1
JP2001131389A
1
JP2001151888A
1
JP2001189166A
1
JP2001213938A
1
JP2001288248A
1
JP2001294639A
1
JP2002012758A
1
JP2002060679A
1
JP2002114727A
1
JP2002155123A
1
JP2002201337A
1
JP2002226696A
1
JP2002302695A
1
JP2002327051A
1
JP2002370963A
2
JP2002542371A
3
JP2003089557A
1
JP2003201334A
1
JP2003238472A
1
JP2003311160A
1
JP2003501541A
6
JP2003514073A
2
JP2004155657A
1
JP2005113140A
1
JP2005206845A
1
JP2005514484A
3
JP2005516090A
2
JP2005522572A
1
JP2005527113A
4
JP2006003860A
1
JP2006117664A
1
JP2006199772A
1
JP2007203670A
1
JP2007284724A
1
JP2007512406A
2
JP2008007818A
1
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:49:57 GMT 2025
Edited
by admin
on Mon Mar 31 21:49:57 GMT 2025
Record UNII
8M5933D775
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
J53.970H
Preferred Name English
BIS(2,3-EPOXYPROPYL) ETHER
Systematic Name English
BIS(2,3-EPOXY-1-PROPYL) ETHER
Systematic Name English
NSC-54739
Code English
DIALLYL ETHER DIOXIDE
Common Name English
DGE
Common Name English
DI-2,3-EPOXYPROPYL ETHER
Common Name English
2-(OXIRAN-2-YLMETHOXYMETHYL)OXIRANE
Systematic Name English
2,2'-(OXYBIS(METHYLENE))BIS(OXIRANE)
Systematic Name English
DIGLYCIDYL ETHER
Systematic Name English
OXIRANE, 2,2'-(OXYBIS(METHYLENE))BIS-
Systematic Name English
ETHER, BIS(2,3-EPOXYPROPYL)
Systematic Name English
1,2,6,7-DIEPOXY-4-OXAHEPTANE
Systematic Name English
DIEPOXY PROPYL ETHER
Common Name English
Code System Code Type Description
WIKIPEDIA
Diglycidyl ether
Created by admin on Mon Mar 31 21:49:57 GMT 2025 , Edited by admin on Mon Mar 31 21:49:57 GMT 2025
PRIMARY
CAS
2238-07-5
Created by admin on Mon Mar 31 21:49:57 GMT 2025 , Edited by admin on Mon Mar 31 21:49:57 GMT 2025
PRIMARY
NSC
54739
Created by admin on Mon Mar 31 21:49:57 GMT 2025 , Edited by admin on Mon Mar 31 21:49:57 GMT 2025
PRIMARY
EPA CompTox
DTXSID4051871
Created by admin on Mon Mar 31 21:49:57 GMT 2025 , Edited by admin on Mon Mar 31 21:49:57 GMT 2025
PRIMARY
HSDB
342
Created by admin on Mon Mar 31 21:49:57 GMT 2025 , Edited by admin on Mon Mar 31 21:49:57 GMT 2025
PRIMARY
FDA UNII
8M5933D775
Created by admin on Mon Mar 31 21:49:57 GMT 2025 , Edited by admin on Mon Mar 31 21:49:57 GMT 2025
PRIMARY
ECHA (EC/EINECS)
218-802-6
Created by admin on Mon Mar 31 21:49:57 GMT 2025 , Edited by admin on Mon Mar 31 21:49:57 GMT 2025
PRIMARY
PUBCHEM
16704
Created by admin on Mon Mar 31 21:49:57 GMT 2025 , Edited by admin on Mon Mar 31 21:49:57 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966